title: Comment on: "Enzalutamide: A Step Towards Pharmacokinetic-Based Dosing in Men with Metastatic Castration-Resistant Prostate Cancer".
authors.affiliation: Clinical Pharmacology and DMPK, Medivation Inc., 36th Floor, 525 Market Street, San Francisco, CA, 94105, USA. Jackie.Gibbons@medivation.com.
authors.forename: Jacqueline A
authors.initials: JA
authors.lastname: Gibbons
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D006801:Humans; D008297:Male; D010669:Phenylthiohydantoin / Q000031:analogs & derivatives*; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy* / Q000378:metabolism*
chemical_list: D000970:Antineoplastic Agents; D010669:Phenylthiohydantoin